| Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on … PN Patsalos, DJ Berry, BFD Bourgeois, JC Cloyd, TA Glauser, ... Epilepsia 49 (7), 1239-1276, 2008 | 1258 | 2008 |
| Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial JJ Cereghino, V Biton, B Abou-Khalil, F Dreifuss, LJ Gauer, I Leppik, ... Neurology 55 (2), 236-242, 2000 | 688 | 2000 |
| Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study TS Walczak, IE Leppik, M D’amelio, J Rarick, E So, P Ahman, K Ruggles, ... Neurology 56 (4), 519-525, 2001 | 651 | 2001 |
| Double-blind study of lorazepam and diazepam in status epilepticus. PB Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE JAMA 249 (11), 1452-1454, 1983 | 495 | 1983 |
| Lamotrigine clearance during pregnancy TA Tran, IE Leppik, K Blesi, ST Sathanandan, R Remmel Neurology 59 (2), 251-255, 2002 | 315 | 2002 |
| Zonisamide: chemistry, mechanism of action, and pharmacokinetics IE Leppik Seizure 13, S5-S9, 2004 | 275 | 2004 |
| Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures E Faught, R Ayala, GG Montouris, IE Leppik, Zonisamide 922 Trial Group Neurology 57 (10), 1774-1779, 2001 | 264 | 2001 |
| Hyponatremia from oxcarbazepine and carbamazepine X Dong, IE Leppik, J White, J Rarick Neurology 65 (12), 1976-1978, 2005 | 238 | 2005 |
| Neurologic prognosis after cardiopulmonary arrest: III. Seizure activity BD Snyder, WA Hauser, RB Loewenson, IE Leppik, M Ramirez-Lassepas, ... Neurology 30 (12), 1292-1292, 1980 | 228* | 1980 |
| Intravenous phenytoin: clinical and pharmacokinetic aspects RE Cranford, IE Leppik, B Patrick, CB Anderson, B Kostick Neurology 28 (9), 874-874, 1978 | 215 | 1978 |
| Felbamate for partial seizures: results of a controlled clinical trial IE Leppik, FE Dreifuss, GW Pledger, NM Graves, N Santilli, I Drury, ... Neurology 41 (11), 1785-1785, 1991 | 194 | 1991 |
| Discontinuation of levetiracetam because of behavioral side effects: a case-control study JR White, TS Walczak, IE Leppik, J Rarick, T Tran, TE Beniak, ... Neurology 61 (9), 1218-1221, 2003 | 182 | 2003 |
| Felbamate: a double‐blind controlled trial in patients undergoing presurgical evaluation of partial seizures B Bourgeois, IE Leppik, JC Sackellares, K Laxer, R Lesser, ... Neurology 43 (4), 693-693, 1993 | 174 | 1993 |
| Efficacy and safety of zonisamide: results of a multicenter study IE Leppik, LJ Willmore, RW Homan, G Fromm, KJ Oommen, JK Penry, ... Epilepsy Research 14 (2), 165-173, 1993 | 171 | 1993 |
| Salivary levels of anticonvulsants: a practical approach to drug monitoring JJ McAULIFFE, AL Sherwin, IE Leppik, SA Fayle, CE Pippenger Neurology 27 (5), 409-409, 1977 | 159 | 1977 |
| Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial BM Uthman, AJ Rowan, PA Ahmann, IE Leppik, SC Schachter, ... Archives of Neurology 55 (1), 56-62, 1998 | 153 | 1998 |
| Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics. JC Cloyd, TE Lackner, IE Leppik Archives of family medicine 3 (7), 589-598, 1994 | 153 | 1994 |
| Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use TE Lackner, JC Cloyd, LW Thomas, IE Leppik Epilepsia 39 (10), 1083-1087, 1998 | 152 | 1998 |
| The KEEPER™ trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study MJ Morrell, I Leppik, J French, J Ferrendelli, J Han, L Magnus Epilepsy research 54 (2-3), 153-161, 2003 | 151 | 2003 |
| Contemporary diagnosis and management of the patient with epilepsy IE Leppik Handbooks in Health Care, 2006 | 148 | 2006 |
